OCT and OCTA qualitative parameters
| Frequency | Per cent | |
| CME score | ||
| Absent/not evaluable | 12/16 | 75.00 |
| Reduced | 4/4 | 100.00 |
| ND score | ||
| Absent/not evaluable | 3/16 | 18.75 |
| Reduced | 11/13 | 84.62 |
| Stable | 2/13 | 15.38 |
| Fine vessel density score | ||
| Reduced | 12/16 | 75.00 |
| Stable | 3/16 | 18.75 |
| Increased | 1/16 | 6.25 |
| Largest vessel calibre score | ||
| Absent/not evaluable | 1 | 6.25 |
| Reduced | 2/15 | 13.33 |
| Stable | 10/15 | 66.67 |
| Increased | 3/15 | 20.00 |
| Choroidal flow void signal score | ||
| Absent/not evaluable | 9/16 | 56.25 |
| Stable | 4/7 | 57.14 |
| Increased | 3/7 | 42.85 |
CME, cystoid macular oedema; ND, neuroretinal detachment; OCT, optical coherence tomography; OCTA, OCT angiography.